This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Mar;57(2):143-4.

Editorial: New therapies for osteogenic sarcoma

C J Campbell, J Cohen, W F Enneking

PMID: 1054022

Editorial: New therapies for osteogenic sarcoma

C J Campbell et al. J Bone Joint Surg Am. 1975 Mar.

. 1975 Mar;57(2):143-4.

Authors

C J Campbell, J Cohen, W F Enneking

PMID: 1054022

No abstract available

PubMed Disclaimer

Similar articles

The therapy of osteogenic sarcoma: current status and thoughts for the future.
Friedman MA, Carter SK. Friedman MA, et al. J Surg Oncol. 1972;4(5):482-510. doi: 10.1002/jso.2930040512. J Surg Oncol. 1972. PMID: 4566220 Review. No abstract available.
[Association of radical surgery and cyclic polychemotherapy (with vincristine, methotrexate and adriamycin) in the treatment of some forms of osteosarcoma. Preliminary results].
Pagani PA, Bacci G, Figus E, Cagnano R, Donati U. Pagani PA, et al. Chir Organi Mov. 1975;62(1):81-92. Chir Organi Mov. 1975. PMID: 1056295 Italian. No abstract available.
Adoptive immunotherapy in primary osteosarcoma. An interim report.
Neff JR, Enneking WF. Neff JR, et al. J Bone Joint Surg Am. 1975 Mar;57(2):145-8. J Bone Joint Surg Am. 1975. PMID: 1054023 No abstract available.
Treatment by amputation and chemotherapy.
Makin M, Sulkes A, Lowe J. Makin M, et al. Prog Clin Biol Res. 1982;99:107-10. Prog Clin Biol Res. 1982. PMID: 6983079 No abstract available.
An update of Scandinavian studies of osteosarcoma.
Elomaa I. Elomaa I. Cancer Treat Res. 1993;62:293-8. doi: 10.1007/978-1-4615-3518-8_35. Cancer Treat Res. 1993. PMID: 8096745 Review. No abstract available.

See all similar articles

Cited by

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma.
Tsukahara T, Kawaguchi S, Torigoe T, Kimura S, Murase M, Ichimiya S, Wada T, Kaya M, Nagoya S, Ishii T, Tatezaki S, Yamashita T, Sato N. Tsukahara T, et al. Cancer Sci. 2008 Feb;99(2):368-75. doi: 10.1111/j.1349-7006.2008.00695.x. Cancer Sci. 2008. PMID: 18271936 Free PMC article.
Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
Tsukahara T, Emori M, Murata K, Hirano T, Muroi N, Kyono M, Toji S, Watanabe K, Torigoe T, Kochin V, Asanuma H, Matsumiya H, Yamashita K, Himi T, Ichimiya S, Wada T, Yamashita T, Hasegawa T, Sato N. Tsukahara T, et al. J Biol Chem. 2014 Aug 8;289(32):22035-47. doi: 10.1074/jbc.M114.568725. Epub 2014 Jun 24. J Biol Chem. 2014. PMID: 24962571 Free PMC article.
Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.
Kawano M, Nishida H, Nakamoto Y, Tsumura H, Tsuchiya H. Kawano M, et al. Clin Orthop Relat Res. 2010 May;468(5):1373-83. doi: 10.1007/s11999-010-1302-z. Epub 2010 Mar 16. Clin Orthop Relat Res. 2010. PMID: 20232181 Free PMC article.
A quest for therapeutic antigens in bone and soft tissue sarcoma.
Kawaguchi S, Wada T, Tsukahara T, Ida K, Torigoe T, Sato N, Yamashita T. Kawaguchi S, et al. J Transl Med. 2005 Aug 8;3:31. doi: 10.1186/1479-5876-3-31. J Transl Med. 2005. PMID: 16086842 Free PMC article.
HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor.
Tsukahara T, Kawaguchi S, Torigoe T, Takahashi A, Murase M, Kano M, Wada T, Kaya M, Nagoya S, Yamashita T, Sato N. Tsukahara T, et al. J Transl Med. 2009 Jun 12;7:44. doi: 10.1186/1479-5876-7-44. J Transl Med. 2009. PMID: 19523231 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer